Neuromuscular Blockade - Reversal of Neuromuscular Blockade

Neuromuscular Blockade - Reversal of Neuromuscular Blockade is a topic covered in the Clinical Anesthesia Procedures.

To view the entire topic, please or .

Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drugs, procedures, and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and PRIME Journals. Explore these free sample topics:

-- The first section of this topic is shown below --

Recovery from SCh-induced depolarizing blockade

Recovery from SCh-induced depolarizing blockade usually occurs within 5 to 10 minutes following a 1 mg/kg IV dose. Patients with atypical or inhibited plasma cholinesterase could have a greatly prolonged duration of blockade. Reversal of phase II blockade occurs spontaneously within 10 to 15 minutes in approximately 50% of patients. It is advisable to allow patients with prolonged blockade to recover spontaneously for 20 to 25 minutes and then reversal with an anticholinesterase agent may be attempted if there is no further improvement in twitch strength. Earlier reversal could potentiate the block.

-- To view the remaining sections of this topic, please or --

Recovery from SCh-induced depolarizing blockade

Recovery from SCh-induced depolarizing blockade usually occurs within 5 to 10 minutes following a 1 mg/kg IV dose. Patients with atypical or inhibited plasma cholinesterase could have a greatly prolonged duration of blockade. Reversal of phase II blockade occurs spontaneously within 10 to 15 minutes in approximately 50% of patients. It is advisable to allow patients with prolonged blockade to recover spontaneously for 20 to 25 minutes and then reversal with an anticholinesterase agent may be attempted if there is no further improvement in twitch strength. Earlier reversal could potentiate the block.

There's more to see -- the rest of this entry is available only to subscribers.